S&P ASX All Technology

3,049.90

-0.57%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GRFS

Grifols (GRFS)

Grifols SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GRFS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
20/04/2024	06:42	PR Newswire (US)	Grifols 2023 Annual Report on Form 20-F filed with the SEC	NASDAQ:GRFS	Grifols SA
18/04/2024	23:30	GlobeNewswire Inc.	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.	NASDAQ:GRFS	Grifols SA
15/04/2024	21:06	IH Market News	Samsung Surpasses Apple in Q1 Smartphone Market; Salesforce in Talks to Acquire Informatica, and More News	NASDAQ:GRFS	Grifols SA
04/04/2024	19:00	GlobeNewswire Inc.	Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	NASDAQ:GRFS	Grifols SA
23/03/2024	00:07	IH Market News	FedEx Soars 13% with Profits Above Forecasts, Nike Hit by China Slowdown, and Latest News	NASDAQ:GRFS	Grifols SA
08/03/2024	22:19	IH Market News	CNOOC Oil Field Discovery in South China Sea, Grifols Surges 18% After KPMG Approval, and Latest News	NASDAQ:GRFS	Grifols SA
14/02/2024	19:16	GlobeNewswire Inc.	Grifols announces positive topline phase 3 fibrinogen clinical trial results	NASDAQ:GRFS	Grifols SA
27/01/2024	09:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
16/01/2024	22:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
12/01/2024	22:10	IH Market News	Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More	NASDAQ:GRFS	Grifols SA
11/01/2024	05:08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
11/01/2024	00:59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
10/01/2024	22:21	IH Market News	Wall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and More	NASDAQ:GRFS	Grifols SA
10/01/2024	06:49	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
10/01/2024	00:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
30/12/2023	01:59	Dow Jones News	Grifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down Debt	NASDAQ:GRFS	Grifols SA
30/12/2023	01:46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
30/12/2023	01:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
16/11/2023	21:00	PR Newswire (US)	Grifols launches new solution to facilitate pre-transfusion compatibility testing in multiple myeloma patients	NASDAQ:GRFS	Grifols SA
16/11/2023	00:00	GlobeNewswire Inc.	Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin Deficiency	NASDAQ:GRFS	Grifols SA
07/11/2023	00:00	GlobeNewswire Inc.	GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023	NASDAQ:GRFS	Grifols SA
03/11/2023	04:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
25/10/2023	09:30	GlobeNewswire Inc.	Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD	NASDAQ:GRFS	Grifols SA
20/10/2023	23:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
19/10/2023	23:00	GlobeNewswire Inc.	GigaGen Granted Expansion of Contract with US Department of Defense to Develop Synthetic Human Antibody Treatments for Botulinum Neurotoxins	NASDAQ:GRFS	Grifols SA
28/09/2023	22:00	GlobeNewswire Inc.	GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564	NASDAQ:GRFS	Grifols SA
01/08/2023	22:00	GlobeNewswire Inc.	Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and Analytics	NASDAQ:GRFS	Grifols SA
28/07/2023	01:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
20/07/2023	22:15	GlobeNewswire Inc.	Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients	NASDAQ:GRFS	Grifols SA
18/07/2023	22:00	GlobeNewswire Inc.	Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis	NASDAQ:GRFS	Grifols SA